Evidence map›Paper›PMID 40377359›Full record

Trial reportJournal of clinical pharmacology2025

Dextromethorphan Versus Dextrorphan: A Quantitative Comparison of Antitussive Potency Following Separate Administration of Metabolite.

Saeed Rezaee, Caroline E Wright, Alyn H Morice, Amin Rostami-Hodjegan

Abstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Journal of clinical pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Saeed RezaeeCentre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0002-6135-9610
Caroline E WrightRespiratory Medicine, Centre for Clinical Science, Hull York Medical School, Hull, UK.
Alyn H MoriceRespiratory Medicine, Centre for Clinical Science, Hull York Medical School, Hull, UK.
Amin Rostami-HodjeganCentre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK.

Funding

Procter and Gamble Company
6 · The paper itself

Abstract

To assess the antitussive effects of dextrorphan (DOR) relative to its parent compound, dextromethorphan (DEX) a double-blind, randomized, placebo-controlled crossover study was conducted in 23 healthy volunteers using citric acid cough challenge test after administering placebo, DEX, or DOR. Plasma concentrations and cough frequency were monitored over 24 h, followed by model independent analysis and pharmacokinetic-pharmacodynamic (PKPD) modelling to discern the relative potency of each moiety. Model-independent pairwise analysis of the area under the effect curve (AUEC₀₋₂₄

Indexed as

Antitussive AgentsCoughDextromethorphanDextrorphanAdultCitric AcidCross-Over StudiesDouble-Blind MethodFemaleHumansMaleMiddle AgedModels, BiologicalYoung AdultAntitussive AgentsCitric AcidDextromethorphanDextrorphanantitussivedextromethorphandextrorphanrelative potency

Identifiers

PMID40377359
PMCPMC12555100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.